🆕Study launched to investigate whether insulin levels influence how women with the most common type of breast cancer respond to treatment.
Trans-EndoNET will examine the relationship between insulin levels & response to aromatise inhibitors in women with ER+HER2- breast cancer.
New clinical study launched examining the role of insulin in breast cancer treatment response
A new clinical study has launched to investigate whether insulin levels influence how women with the most common type of breast cancer respond to treatment.
